These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8952740)

  • 1. [Calcium inhibitors and post-infarction].
    Vacheron A
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):465-7. PubMed ID: 8952740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Do calcium inhibitors have any role in secondary prevention of myocardial infarction?].
    Vacheron A; Tabone X
    Ann Cardiol Angeiol (Paris); 1992 Jun; 41(6):343-7. PubMed ID: 1359828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists after acute myocardial infarction.
    Ferrario M; Specchia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S75-8. PubMed ID: 2483238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction.
    Gibson RS
    Circulation; 1989 Dec; 80(6 Suppl):IV107-19. PubMed ID: 2574639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
    Gambelli G; Donati R; Mezzanotte R; Pozzar F; Cesario AS; Schiavo B; Pau F
    G Ital Cardiol; 1998 Mar; 28(3):249-58. PubMed ID: 9561879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Which medical treatment after myocardial infarction?].
    Castaigne A; Pham I; Saal JP; Albo C; Verschuren P; Perchet H
    Rev Prat; 1992 Nov; 42(17):2169-73. PubMed ID: 1363253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in the therapy of acute myocardial infarction.
    Stazi F; Verde M; Stazi C; Di Gennaro M
    Minerva Cardioangiol; 2000; 48(1-2):29-38. PubMed ID: 10829585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R; McMurray JJ
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D
    Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Care of acute myocardial infarction in Oklahoma: an update from the Cooperative Cardiovascular Project.
    Bratzler DW; Oehlert WH; Walkingstick K; Murray CK; Shook C;
    J Okla State Med Assoc; 2001 Oct; 94(10):443-50. PubMed ID: 11641999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.